Nova In Silico

Curated by Signal

Developer of AI-driven in silico clinical trial platform for improving decision-making in biology, medicine, and data science

Health Technologynovainsilico.ai

Overview

Developer of AI-driven in silico clinical trial platform for improving decision-making in biology, medicine, and data science. The platform, Jinko streamlines clinical trials using disease models and digital patients.

Key facts

Founded: 2010
Headquarters: Lyon, France
Stage: Sign up to view
Industry: Health Technology

Business model

1 product or service: Sign up to view

Contact

Email: Sign up to view
Phone: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

Appy Care
Mobile application offering medication reminders and management for users
Health TechnologyParis, France
Predict4Health
Platform offers solutions for drug development using AI and data analytics
Health TechnologyParis, France
Medylio
Provider of patient communication and medical telemonitoring software for clinical management
Health TechnologyFrance

About Nova In Silico

What does Nova In Silico do?

Developer of AI-driven in silico clinical trial platform for improving decision-making in biology, medicine, and data science.

Where is Nova In Silico headquartered?

Nova In Silico is headquartered in Lyon, France.

When was Nova In Silico founded?

Nova In Silico was founded in 2010.

Which sector is Nova In Silico in?

Nova In Silico operates in Health Technology.

Who are Nova In Silico's competitors?

Companies similar to Nova In Silico include Appy Care, Predict4Health, and Medylio.